Dai Nippon Printing Co Ltd (DNP) is a provider of publishing and media services, imaging communications, and packaging products and services. The company's product portfolio includes magazines, calendars, digital pens, display components, dictionaries, residential interior materials, and reader/writer modules.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

DNP's R&D divisions focuses on developing new products and enhancing its existing offerings to align with evolving market trends. The company recognizes research and development as a vital component of its operations, particularly for expanding its business through the advancement of printing and information (P&I) technologies. DNP's R&D initiatives are rooted in its basic technologies, developed through the printing process and refined by integrating the latest technologies. The company leverages its core technologies, including project planning, design, information processing, microfabrication, precision coating, and post-processing, supported by material development and evaluation and analysis. To accelerate technological progress, DNP actively engages in collaborations with other companies that possess cutting-edge technologies while also fostering its proprietary innovations. The company operates an R&D Center that facilitates activities across various sectors, from fundamental development to technology application and the launch of new businesses. In FY2025, the company has 12,564 Japan patents. DNP's R&D centers are located in Chiba, Tokyo, Ibaraki, Saitama, Okayama, Ishikawa, and Ibaraki. In FY2025, the company allocated JPY37,561 million to R&D, representing 2.5% of its revenue.